Tuesday, August 3, 2021
Warwick, RI (Aug. 3, 2021) – Yale New Haven Health has opened a new Northeast Medical Group urology office at 176 Toll Gate Road, Suite 301, Warwick, RI.
The office is currently welcoming new patients. To schedule an appointment please call 401-244-9090.
The office is staffed by providers from Northeast Medical Group (NEMG) who are affiliated with Westerly Hospital, a member of Yale New Haven Health. The team includes Joseph Renzulli, MD, regional medical director and chief of urology at Westerly Hospital; Joseph Heineman, MD; E. Bradley Miller, MD; Emily Henault, PA; and Lauren Houle, APRN.
In Warwick, NEMG urologists offer comprehensive and coordinated care to both men and women, as well as children. Conditions specific to men include erectile dysfunction, male infertility, enlarged prostate and testicular cancer. Female urology involves the diagnosis and treatment of urinary tract disorders most prevalent in women. Advanced, minimally invasive procedures are conveniently performed at Westerly Hospital.
1/15/2026
Bridgeport Hospital recognized with two Beacon Awards for ExcellenceMILFORD, CT (January 15, 2026) – The American Association of Critical-Care Nurses (AACN) has recognized the Progressive Care Unit (PCU) and the Medical-Coronary Intensive Care Unit (MICU) at Bridgeport Hospital with silver-level Beacon Awards for Excellence.
1/13/2026
Experienced Yale psychiatrist Kourtney Koslosky, MD, tapped to lead Greenwich Hospital’s Psychiatry and Behavioral Health DepartmentGREENWICH, CT (December 4, 2025) - In October 2025, Greenwich Hospital appointed Kourtney Koslosky, MD, as the new chair of its Psychiatry and Behavioral Health department. With more than a decade of experience at Yale School of Medicine (YSM) and the Yale New Haven Health System (YNHHS), Dr. Koslosky brings both academic and clinical expertise to her new leadership post.
1/13/2026
Yale New Haven Health offers new technology to detect coronary artery diseaseNew Haven, CT (Jan. 12, 2026) — Yale New Haven Health is the first health system in Connecticut to offer a new positron emission tomography (PET) imaging agent that offers the potential to significantly enhance clinicians’ ability to detect coronary artery disease.
